Link to the Show / Show NotesSeptember 22, 2009 - Part 2 (Q&A)
Emerging Therapies in NHL: Understanding Your Options
This program featured Andrew D. Zelenetz, MD, PhD, Chief, Lymphoma Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech BioOncology and biogen idec.

Play in your Iphone